生命科學設備市場規模、佔有率和成長分析(按技術、應用、最終用戶和地區分類)—2026-2033年產業預測
市場調查報告書
商品編碼
1897897

生命科學設備市場規模、佔有率和成長分析(按技術、應用、最終用戶和地區分類)—2026-2033年產業預測

Life Science Instrumentation Market Size, Share, and Growth Analysis, By Technology (Spectroscopy, Chromatography), By Application (Research Applications, Clinical & Diagnostics Applications), By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,生命科學設備市場規模將達到 775.9 億美元,到 2025 年將達到 826.3 億美元,到 2033 年將達到 1367.5 億美元,預測期(2026-2033 年)的複合年成長率為 6.5%。

生命科學設備市場預計將迎來顯著成長,這主要得益於生物技術、製藥、食品飲料和農業等各個領域對先進分析工具日益成長的需求。研發投入的增加、實驗室數量的成長以及對次世代定序技術在疾病分析方面的顯著關注,是推動這一活性化的主要因素。此外,旨在促進醫療設備和生命科學設備技術進步的公私合營投資的增加也對市場產生了積極影響。慢性病盛行率的上升也推動了檢測需求的成長,進一步促進了市場擴張。主要企業不斷推出創新產品,可望提高診斷準確性,最終實現個人化治療。

生命科學設備市場促進因素

推動生命科學設備市場成長的關鍵因素之一是政府主導的旨在推動醫學和科學研究的各項舉措。這些措施包括增加研究計劃經費、提供創新津貼、支援實驗室設備現代化。各國政府正投資開發先進技術和基礎設施,以提升研究能力,從而創造有利於創新和尖端設備應用的環境。這種對改善醫療效果和加速科學發現的日益重視,刺激了對先進生命科學設備的需求,最終推動市場擴張,並為製造商和服務供應商創造新的機會。

生命科學設備市場限制因素

生命科學設備市場面臨許多挑戰,阻礙了其成長潛力。其中一個突出問題是熟練專業人才短缺,這限制了先進設備和技術的有效利用。此外,藥物研發過程的高成本會抑制投資,減緩研發進程。同時,新興經濟體普遍存在資金短缺問題,這限制了其取得先進生命科學設備和技術。這些因素共同構成了市場創新和擴張的重大障礙。

生命科學設備市場趨勢

生命科學儀器市場正迅速採用人工智慧 (AI) 技術來實現實驗室自動化並提高分析流程的準確性。這一趨勢的驅動力在於人工智慧技術的進步,這些進步正推動著旨在提高實驗室檢測操作效率和準確性的高科技儀器的研發。主要企業正策略性地收購人工智慧功能並將其整合到現有平台中,以提升氣相層析法和質譜儀等儀器的性能。這種整合旨在簡化高通量實驗室的工作流程,拓展科學研究和診斷能力的邊界,同時將人工智慧打造為競爭格局中的關鍵差異化因素。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球生命科學設備市場規模(依技術及複合年成長率分類)(2026-2033 年)

  • 光譜學
  • 層析法
  • 聚合酵素鏈鎖反應(PCR)
  • 免疫檢測
  • 冷凍乾燥
  • 液體處理系統
  • 臨床化學分析儀
  • 顯微鏡
  • 流式細胞技術
  • 次世代定序(NGS)
  • 離心機
  • 電泳
  • 細胞計數
  • 其他技術

全球生命科學設備市場規模(依應用領域及複合年成長率分類)(2026-2033 年)

  • 研究用途
  • 臨床和診斷用途
  • 其他用途

全球生命科學設備市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院和診斷檢查室
  • 製藥和生物技術公司
  • 學術和研究機構
  • 農業和食品工業
  • 環境檢測實驗室
  • 臨床研究所
  • 其他最終用戶

全球生命科學設備市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2021-2023年營收年比比較

主要企業簡介

  • Thermo Fisher Scientific(USA)
  • Danaher Corporation(USA)
  • Agilent Technologies(USA)
  • Illumina(USA)
  • PerkinElmer(USA)
  • Bio-Rad Laboratories(USA)
  • Bruker Corporation(USA)
  • Merck KGaA(Germany)
  • BD(Becton, Dickinson and Company)(USA)
  • Waters Corporation(USA)
  • Shimadzu Corporation(Japan)
  • Hitachi High-Technologies Corporation(Japan)
  • Oxford Instruments(UK)
  • Horiba, Ltd.(Japan)
  • JASCO Corporation(Japan)
  • Analytik Jena AG(Germany)
  • Teledyne Technologies Incorporated(USA)
  • LEICA Microsystems(Germany)
  • Retsch GmbH(Germany)
  • Sartorius AG(Germany)

結論與建議

簡介目錄
Product Code: SQMIG35A2512

Life Science Instrumentation Market size was valued at USD 77.59 Billion in 2024 and is poised to grow from USD 82.63 Billion in 2025 to USD 136.75 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The life science instrumentation market is poised for significant growth driven by increasing demand for advanced analytical tools in various sectors including biotechnology, pharmaceuticals, food and beverage, and agriculture. This growth is fueled by escalating research and development activities, the proliferation of laboratories, and a notable focus on next-generation sequencing technologies, which enhance disease analysis. The market is also benefiting from rising investments in public-private partnerships aimed at technological advancements in medical devices and life science instruments. Additionally, the heightened prevalence of chronic diseases is leading to greater testing needs, further driving market expansion. The continuous introduction of innovative products by leading companies is expected to enhance diagnostic accuracy, ultimately tailoring treatments to individual patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Instrumentation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Life Science Instrumentation Market Segments Analysis

Global Life Science Instrumentation Market is segmented by technology, application, end user and region. Based on technology, the market is segmented into spectroscopy, chromatography, polymerase chain reaction, immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing (ngs), centrifuges, electrophoresis, cell counting and other technologies. Based on application, the market is segmented into research applications, clinical & diagnostics applications and other applications. Based on end user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries, environmental testing laboratories, clinical research organizations and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Life Science Instrumentation Market

A significant factor fueling the growth of the Life Science Instrumentation market is the rise in government initiatives aimed at advancing healthcare and scientific research. These initiatives often include increased funding for research projects, grants for innovation, and support for modernizing laboratory equipment. Governments are investing in the development of advanced technologies and infrastructure that enhance research capabilities, thereby fostering an environment that encourages innovation and the adoption of cutting-edge instrumentation. This heightened focus on improving healthcare outcomes and promoting scientific discovery stimulates demand for sophisticated life science instruments, ultimately driving market expansion and creating new opportunities for manufacturers and service providers.

Restraints in the Life Science Instrumentation Market

The Life Science Instrumentation market faces several challenges that can hinder its growth potential. One of the prominent issues is the shortage of skilled professionals, which limits the effective utilization of sophisticated instruments and technologies. Additionally, the high costs associated with the drug discovery process can deter investment and slow down research and development efforts. Furthermore, emerging economies are often plagued by a scarcity of funding, which restricts access to advanced life science instrumentation and technologies. Together, these factors create significant hurdles that can impede innovation and expansion in the market.

Market Trends of the Life Science Instrumentation Market

The Life Science Instrumentation market is increasingly embracing Artificial Intelligence to enhance laboratory automation and precision in analytical processes. This trend is being driven by advancements in AI technologies that facilitate the development of high-tech instruments designed to improve operational efficiency and accuracy in lab testing. Major players in the sector are strategically acquiring AI capabilities to integrate them into existing platforms, thereby elevating the performance of instruments such as gas chromatography and mass spectrometry. This integration aims to streamline workflows in high-throughput labs, pushing the boundaries of scientific research and diagnostic capabilities, and positioning AI as a key differentiator in the competitive landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Life Science Instrumentation Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Spectroscopy
  • Chromatography
  • Polymerase Chain Reaction
  • Immunoassays
  • Lyophilization
  • Liquid Handling Systems
  • Clinical Chemistry Analyzers
  • Microscopy
  • Flow Cytometry
  • Next-Generation Sequencing (Ngs)
  • Centrifuges
  • Electrophoresis
  • Cell Counting
  • Other Technologies

Global Life Science Instrumentation Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Research Applications
  • Clinical & Diagnostics Applications
  • Other Applications

Global Life Science Instrumentation Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals And Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Agriculture & Food Industries
  • Environmental Testing Laboratories
  • Clinical Research Organizations
  • Other End Users

Global Life Science Instrumentation Market Size & CAGR (2026-2033)

  • North America (Technology, Application, End User)
    • USA
    • Canada
  • Europe (Technology, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi High-Technologies Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Instruments (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Horiba, Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JASCO Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Analytik Jena AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teledyne Technologies Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LEICA Microsystems (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Retsch GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations